Literature DB >> 23865437

Postmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weight.

R B Song1, C H Vite, C W Bradley, J R Cross.   

Abstract

BACKGROUND: Intracranial neoplasia of dogs is frequently encountered in veterinary medicine, but large-scale studies on prevalence are lacking.
OBJECTIVES: To determine the prevalence of intracranial neoplasia in a large population of dogs examined postmortem and the relationship between breed, age, and weight with the presence of primary intracranial neoplasms. ANIMALS: All dogs that underwent postmortem examination from 1986 through 2010 (n = 9,574), including dogs with a histopathologic diagnosis of primary (n = 227) and secondary (n = 208) intracranial neoplasia.
METHODS: Retrospective evaluation of medical records from 1986 through 2010.
RESULTS: Overall prevalence of intracranial neoplasia in this study's population of dogs was 4.5%. A statistically significant higher prevalence of primary intracranial neoplasms was found in dogs with increasing age and body weights. Dogs ≥15 kg had an increased risk of meningioma (odds ratio 2.3) when compared to dogs <15 kg. The Boxer, Boston Terrier, Golden Retriever, French Bulldog, and Rat Terrier had a significantly increased risk of primary intracranial neoplasms while the Cocker Spaniel and Doberman Pinscher showed a significantly decreased risk of primary intracranial neoplasms. CONCLUSIONS AND CLINICAL IMPORTANCE: Intracranial neoplasia in dogs might be more common than previous estimates. The study suggests that primary intracranial neoplasia should be a strong differential in older and larger breed dogs presenting with signs of nontraumatic intracranial disease. Specific breeds have been identified with an increased risk, and others with a decreased risk of primary intracranial neoplasms. The results warrant future investigations into the role of age, size, genetics, and breed on the development of intracranial neoplasms.
Copyright © 2013 by the American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Brain tumor; Glioma; Meningioma; Prevalence

Mesh:

Year:  2013        PMID: 23865437     DOI: 10.1111/jvim.12136

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  54 in total

1.  A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Authors:  Jennifer W Koehler; Andrew D Miller; C Ryan Miller; Brian Porter; Kenneth Aldape; Jessica Beck; Daniel Brat; Ingrid Cornax; Kara Corps; Chad Frank; Caterina Giannini; Craig Horbinski; Jason T Huse; M Gerard O'Sullivan; Daniel R Rissi; R Mark Simpson; Kevin Woolard; Joanna H Shih; Christina Mazcko; Mark R Gilbert; Amy K LeBlanc
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

Review 2.  Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.

Authors:  Michael R Olin; G Elizabeth Pluhar; Brian M Andersen; Rob Shaver; Nate N Waldron; Christopher L Moertel
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

3.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

4.  Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.

Authors:  A L Bredlau; M A McCrackin; Anjan Motamarry; Kris Helke; Chao Chen; Ann-Marie Broome; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2016

Review 5.  Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

Authors:  Amy K LeBlanc; Christina Mazcko; Diane E Brown; Jennifer W Koehler; Andrew D Miller; C Ryan Miller; R Timothy Bentley; Rebecca A Packer; Matthew Breen; C Elizabeth Boudreau; Jonathan M Levine; R Mark Simpson; Charles Halsey; William Kisseberth; John H Rossmeisl; Peter J Dickinson; Timothy M Fan; Kara Corps; Kenneth Aldape; Vinay Puduvalli; G Elizabeth Pluhar; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2016-05-14       Impact factor: 12.300

Review 6.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

7.  Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.

Authors:  A Courtenay Freeman; Simon R Platt; Shannon Holmes; M Kent; Kelsey Robinson; Elizabeth Howerth; Joe Eagleson; Alexandros Bouras; Milota Kaluzova; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2018-01-19       Impact factor: 4.130

Review 8.  Domestic dogs and cancer research: a breed-based genomics approach.

Authors:  Brian W Davis; Elaine A Ostrander
Journal:  ILAR J       Date:  2014

Review 9.  Dogs are man's best friend: in sickness and in health.

Authors:  R Timothy Bentley; Atique U Ahmed; Amy B Yanke; Aaron A Cohen-Gadol; Mahua Dey
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

10.  Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas.

Authors:  Anna Filley; Mario Henriquez; Tanmoy Bhowmik; Brij Nath Tewari; Xi Rao; Jun Wan; Margaret A Miller; Yunlong Liu; R Timothy Bentley; Mahua Dey
Journal:  J Neurooncol       Date:  2018-01-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.